Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Covergalls: Eco-Friendly High-Visibility Shirt for Women | Alicia Woods, CEO of Covergalls Inc
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Alicia Woods. CEO & Founder of Covergalls Inc.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Chip Paucek on the Evolution and Future of Online Learning | Chip Paucek, CEO , 2U Inc.
00:10:00
Future of American Education: Predictions for 2030
00:10:00
Joseph Jakavalley's Outlook on China's Electric Power Market
00:10:00
Powering Europe's Businesses: The Rise of B2B SaaS and Fintech|Julia Andre,Partner,Index Ventures
00:10:00
Keith Muller, CEO of Atlantic Lithium, Discusses Ewoyaa Project and Future Plans
00:10:00
Empower the body to fight disease|Anders Haegerstrand,Chief Executive Officer,Annexin Pharmaceuticals
00:10:00
Focusing on consumer and creator economy|Geoffrey Woo,Co-Founder and Partner,Anti Fund
00:10:00
Introductory Remarks and Q&A Session at the News Conference on September 3, 2019" - Held by the Schweizerische Nationalbank (Swiss National Bank)
00:10:00
JD.com’s IPO Highlights Investor Confidence Despite Losses, Mark Otto Analyzes Future Chinese E-Commerce Listings
00:10:00
"Jennifer Tejada, CEO of PagerDuty, featured in discussions about Solarmax Technology Inc. and #CloudNY."|Jennifer Tejada is the Chairperson and CEO of PagerDuty
00:10:00
Antler specializes in local Founder Residencies, and invests in founders across industries from Day 1|Youri Doeleman,Partner, Netherlands,Antler
00:10:00
Behind the Scenes: JIC's Stock Selection Process Explained